retatrutide trials safety as a Novel Treatment for Obesity and Type 2 Diabetes ๐๐ฅ๐ฒ๐๐ฎ๐๐ฟ๐๐๐ถ๐ฑ๐ฒ'๐ ๐จ๐ป๐ฒ๐ ๐ฝ๐ฒ๐ฐ๐๐ฒ๐ฑ ๐ฆ๐ถ๐ฑ๐ฒ ๐๐ณ๐ณ๐ฒ๐ฐ๐: ๐ช๐ต๐ฎ๐
Description
Drugs such as semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda, Victoza) were first approved for type 2 diabetes and later for chronic weight management
The starting dose is 3mg, which increases to 7mg after 30 days, with a maximum dose of 14mg based on your healthcare providers assessment
GLP-1 cardiovascular outcomes Multiple large-scale cardiovascular outcomes trials have demonstrated that GLP-1 agonists reduce the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death

They are easier to stop if needed

Hemorrhoids have a number of causes, but often the cause is unknown

Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome